NVS · SUB · DO · Programa de Medicamentos Esenciales

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: subsidiary/issuer «Novartis Caribe, SA» ↔ SEC NVS (CIK 1114448, NOVARTIS AG): 22 non-competitive contracts at the buyer «Programa de Medicamentos Esenciales», amount not stated (≈ $0); method direct (Procesos de Excepción), method selective (Procesos de Excepción), method «Procesos de Excepción»; OCID ocds-6550wx-PROMESECAL-CCC-PEPU-2021-0008, ocds-6550wx-PROMESECAL-CCC-PEEX-2021-0010, ocds-6550wx-PROMESECAL-MAE-PEUR-2021-0016, ocds-6550wx-PROMESECAL-MAE-PEUR-2021-0018, ocds-6550wx-PROMESECAL-MAE-PEUR-2022-0009, ocds-6550wx-PROMESECAL-MAE-PEUR-2022-0010, ocds-6550wx-PROMESECAL-MAE-PEUR-2022-0012, ocds-6550wx-PROMESECAL-MAE-PEUR-2023-0002, ocds-6550wx-PROMESECAL-MAE-PEUR-2023-0007, ocds-6550wx-P; ⚑ REPEAT: already sanctioned SEC by FCPA (2020-06-25 Novartis AG, 2016-03-23 Novartis AG).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

NVS · SUB · DO · Programa de Medicamentos Esenciales

Indicator

Debarred / sanctioned abroad × US SEC issuer

Records behind the indicator

22

Found

4 October 2026

Code

W-01372

Reference

ocds-6550wx-PROMESECAL-CCC-PEPU-2021-0008

Reference

ocds-6550wx-PROMESECAL-CCC-PEEX-2021-0010

Reference

ocds-6550wx-PROMESECAL-MAE-PEUR-2021-0016

Reference

ocds-6550wx-PROMESECAL-MAE-PEUR-2021-0018

Reference

ocds-6550wx-PROMESECAL-MAE-PEUR-2022-0009

Reference

ocds-6550wx-PROMESECAL-MAE-PEUR-2022-0010

Reference

ocds-6550wx-PROMESECAL-MAE-PEUR-2022-0012

Reference

ocds-6550wx-PROMESECAL-MAE-PEUR-2023-0002